Swedish Medical Products Agency grants approval for clinical study of new stem cell based Parkinson’s Disease treatment
By paulina [dot] pettersson [at] med [dot] lu [dot] se (Paulina Pettersson) - published 20 October 2022 Läkemedelsverket godkänner klinisk fas 1- och fas2a-studie för ny stamcellsbaserad behandling av Parkinsons sjukdom An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval